Macular degeneration, cited as the leading cause of blindness in the elderly, is driving rapid growth in the treatment market ...

Eye injections of the drug Avastin, used to treat retinal diseases, bring no greater risk of endophthalmitis, a potentially blinding eye infection, than injections with the much more expensive drug ...

A new compound potentially could offer an alternative to injections for the millions of people who suffer from an eye condition that causes blindness. A new compound developed at the University of ...

W hen diagnosed with diabetic macular edema (DME) in 2017, Sarah Castaneda, 41, thought she would lose her eyesight completely. At least, that’s what her doctor told her would happen if she didn’t ...

Until about 20 years ago, people in the advanced stages of age-related macular degeneration (AMD) were almost certain to lose their central vision. Without the ability to see faces, read or drive, ...

Australian scientists have successfully used an innovative gene therapy technique in the lab to combat a key cause of vision loss in "wet" age-related macular degeneration and diabetic eye disease.

Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.